Angoroside CCAS# 115909-22-3 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 115909-22-3 | SDF | Download SDF |
| PubChem ID | 6444153 | Appearance | White powder |
| Formula | C36H48O19 | M.Wt | 784.75 |
| Type of Compound | Phenylpropanoids | Storage | Desiccate at -20°C |
| Solubility | DMSO : 250 mg/mL (318.57 mM; Need ultrasonic) | ||
| Chemical Name | [(2R,3R,4R,5R,6R)-5-hydroxy-6-[2-(3-hydroxy-4-methoxyphenyl)ethoxy]-4-[(2S,3R,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-2-[[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-3-yl] (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate | ||
| SMILES | CC1C(C(C(C(O1)OC2C(C(OC(C2OC(=O)C=CC3=CC(=C(C=C3)O)OC)COC4C(C(C(CO4)O)O)O)OCCC5=CC(=C(C=C5)OC)O)O)O)O)O | ||
| Standard InChIKey | KLQXMRBGMLHBBQ-FUNGFBQYSA-N | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | Angoroside C has anti-inflammatory effect , it can significantly inhibit LPS-induced PGE(2), NO and TNF-alpha in a concentration-dependent manner; it also exhibits cytotoxic and cytostatic activities against several kinds of cancer cells. Angoroside C has beneficial effects against ventricular remodeling, the mechanism is likely to be related to decreasing the level of Ang Ⅱ, attenuating the mRNA expressions of ET-1 and TGF-β1. |
| Targets | COX | LOX | NO | TNF-α | PGE | MMP(e.g.TIMP) | TGF-β/Smad |
| In vitro | Phenylpropanoid glycosides from Scrophularia scorodonia: in vitro anti-inflammatory activity.[Pubmed: 15010262]Life Sci. 2004 Apr 2;74(20):2515-26.Five phenylpropanoid glycosides isolated from Scrophularia scorodonia L. (Scrophulariaceae), namely angoroside A (1), Angoroside C (2), angoroside D (3), acteoside (4) and isoacteoside (5), had been evaluated as potential inhibitors of some macrophage functions involved in the inflammatory process. |
| In vivo | The effect of angoroside C on pressure overload-induced ventricular remodeling in rats.[Pubmed: 26141756 ]Phytomedicine. 2015 Jul 15;22(7-8):705-12.Our previous study reveals that total rough extract of Radix Scrophulariae has a beneficial effect on ventricular remodeling.
HYPOTHESIS:
After carrying out a series of preliminary experiments, we speculated that Angoroside C may be the effective agent.
STUDY DESIGN:
After oral administration, the effect of Angoroside C on ventricular remodeling was evaluated by using a pressure-overloaded rat model, some related indexes were detected in vivo.
|
| Cell Research | Selective cytotoxic and cytostatic activity of some phenypropanoid glycosides.[Reference: WebLink]Fitoterapia, 1997, 68(5):434-8.
|
Angoroside C Dilution Calculator
Angoroside C Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.2743 mL | 6.3715 mL | 12.7429 mL | 25.4858 mL | 31.8573 mL |
| 5 mM | 0.2549 mL | 1.2743 mL | 2.5486 mL | 5.0972 mL | 6.3715 mL |
| 10 mM | 0.1274 mL | 0.6371 mL | 1.2743 mL | 2.5486 mL | 3.1857 mL |
| 50 mM | 0.0255 mL | 0.1274 mL | 0.2549 mL | 0.5097 mL | 0.6371 mL |
| 100 mM | 0.0127 mL | 0.0637 mL | 0.1274 mL | 0.2549 mL | 0.3186 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Tos-Arg-OH
Catalog No.:BCC2873
CAS No.:1159-15-5
- N1-Methoxymethyl picrinine
Catalog No.:BCN6038
CAS No.:1158845-78-3
- Aurora A Inhibitor I
Catalog No.:BCC2182
CAS No.:1158838-45-9
- Salvianolic acid C
Catalog No.:BCN5376
CAS No.:115841-09-3
- 2,7-Dideacetoxytaxinine J
Catalog No.:BCN7281
CAS No.:115810-14-5
- Tubeimoside III
Catalog No.:BCN2956
CAS No.:115810-13-4
- Tubeimoside II
Catalog No.:BCN2955
CAS No.:115810-12-3
- ent-Atisane-3beta,16alpha,17-triol
Catalog No.:BCN6626
CAS No.:115783-44-3
- 15,16-Dihydro-15-methoxy-16-oxohardwickiic acid
Catalog No.:BCN1612
CAS No.:115783-35-2
- Galanolactone
Catalog No.:BCN6037
CAS No.:115753-79-2
- 1-O-galloyl-6-O-cinnamoylglucose
Catalog No.:BCN8264
CAS No.:115746-69-5
- 6'-O-beta-D-Glucosylgentiopicroside
Catalog No.:BCN2814
CAS No.:115713-06-9
- Tarafenacin D-tartrate
Catalog No.:BCC4148
CAS No.:1159101-48-0
- Salvianolic acid B
Catalog No.:BCN6106
CAS No.:115939-25-8
- Alstonic acid A
Catalog No.:BCN6039
CAS No.:1159579-44-8
- Alstonic acid B
Catalog No.:BCN6040
CAS No.:1159579-45-9
- Poricoic acid AE
Catalog No.:BCN7282
CAS No.:1159753-88-4
- CZC24832
Catalog No.:BCC1507
CAS No.:1159824-67-5
- Abiesadine N
Catalog No.:BCN6041
CAS No.:1159913-80-0
- Caulophine
Catalog No.:BCN7990
CAS No.:1159989-19-1
- TC-I 2000
Catalog No.:BCC6244
CAS No.:1159996-20-9
- Aldicarb
Catalog No.:BCC5475
CAS No.:116-06-3
- 4-Amino-3-hydroxy-1-naphthalenesulfonic acid
Catalog No.:BCC8680
CAS No.:116-63-2
- 1-Amino-4-hydroxyanthraquinone
Catalog No.:BCC8452
CAS No.:116-85-8
Phenylpropanoid glycosides from Scrophularia scorodonia: in vitro anti-inflammatory activity.[Pubmed:15010262]
Life Sci. 2004 Apr 2;74(20):2515-26.
Five phenylpropanoid glycosides isolated from Scrophularia scorodonia L. (Scrophulariaceae), namely angoroside A (1), Angoroside C (2), angoroside D (3), acteoside (4) and isoacteoside (5), had been evaluated as potential inhibitors of some macrophage functions involved in the inflammatory process. These compounds have been tested in two experimental systems: ionophore-stimulated mouse peritoneal macrophages and human platelets serve as source of COX-1 and 5-LOX, and mouse peritoneal macrophages stimulated with E. coli LPS are the means of testing for COX-2, NO and TNF-alpha activity. None of compounds assayed had a significant effect on LTC(4)-release from calcium ionophore-stimulated mouse peritoneal macrophages. However, the release of PGE(2) by mouse peritoneal macrophages stimulated with calcium ionophore was inhibited by most of these compounds. In the TXB(2)-release assay, acteoside (4), angoroside A (1) and Angoroside C (2) showed a significant effect. These five compounds, except Angoroside C (2) significantly inhibited LPS-induced PGE(2), NO and TNF-alpha in a concentration-dependent manner. In LPS-stimulated macrophages, the phenylpropanoid glycoside Angoroside C (2) only had activity on NO. These results indicate that the pharmacology of these compounds may participate in the anti-inflammatory effect of Scrophularia scorodonia.
The effect of angoroside C on pressure overload-induced ventricular remodeling in rats.[Pubmed:26141756]
Phytomedicine. 2015 Jul 15;22(7-8):705-12.
BACKGROUND: Our previous study reveals that total rough extract of Radix Scrophulariae has a beneficial effect on ventricular remodeling. HYPOTHESIS: After carrying out a series of preliminary experiments, we speculated that Angoroside C may be the effective agent. STUDY DESIGN: After oral administration, the effect of Angoroside C on ventricular remodeling was evaluated by using a pressure-overloaded rat model, some related indexes were detected in vivo. METHODS: A model of pressure overloaded ventricular remodeling was produced by abdominal aortic constriction (AAC) in rats. The sham-operated rats underwent an identical surgical procedure except for AAC. AAC rats were randomly divided into five groups: model control group, three Angoroside C treated groups (7.5, 15 and 30 mg.kg(-1)) and captopril treated group (40 mg.kg(-1)). The rats were orally administered with the corresponding drugs or drinking water for 4 weeks. The levels of blood pressure (BP), left ventricular weight index (LVWI) and heart weight index (HWI) were detected. Myocardium tissue was stained with hematoxylin and eosin or picric acid/sirius red for cardiomyocyte cross-section area or collagen content measurements respectively. The concentrations of angiotensin (Ang ), hydroxyproline (Hyp), matrix metalloproteinase 2 (MMP-2), MMP-9 and tissue inhibitor of metalloproteinase-1 (TIMP-1) in myocardium or serum were determined. Real-time RT-PCR was performed to detect the mRNA expressions of endothelin 1 (ET-1), transforming growth factor beta1 (TGF-beta1). RESULTS: Angoroside C significantly reduced the BP, LVWI and HWI, decreased the content of Ang , Hyp, diminished cross sectional area of cardiomyocytes and ameliorated collagen deposition. Additionally, it markedly reduced collagen I and III expressions and regulated matrix metalloproteinase-2, 9 and inhibitors of metalloproteinase expressions. Angoroside C also down regulated the gene expressions of ET-1 and TGF-beta1mRNA in myocardium. CONCLUSION: Angoroside C has beneficial effects against ventricular remodeling. The mechanism is likely to be related to decreasing the level of Ang , attenuating the mRNA expressions of ET-1 and TGF-beta1.
